ADAR1 Capital Management »

Altria shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Altria (MO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Altria

Tip: Access up to 7 years of quarterly data

All positions including Altria held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altria by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $87k 2.0k 43.62
2023-12-31 $242k 6.0k 40.34

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Altria

Vanguard Group
BlackRock
State Street Corporation
Capital World Investors
Charles Schwab Investment Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Northern Trust
Bank of New York Mellon
Bank of America Corporation
Capital Research Global Investors
Legal & General Group
Invesco
Goldman Sachs Group
Pacer Advisors

View all funds holding Altria